🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 23 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/10/2004 | 16,64 | 16,87 | 16,43 | 16,55 | -0,12% | 2,64% | 749.200 |
| 12/10/2004 | 16,85 | 16,90 | 16,35 | 16,57 | -2,27% | 3,29% | 950.600 |
| 11/10/2004 | 16,43 | 17,00 | 16,29 | 16,96 | +4,02% | 4,32% | 985.000 |
| 08/10/2004 | 16,24 | 16,80 | 16,24 | 16,30 | +0,15% | 3,45% | 1.144.400 |
| 07/10/2004 | 16,80 | 16,90 | 16,26 | 16,28 | -4,29% | 3,84% | 923.000 |
| 06/10/2004 | 17,31 | 17,36 | 16,29 | 17,01 | -2,24% | 6,18% | 2.353.000 |
| 05/10/2004 | 17,63 | 17,63 | 17,24 | 17,40 | -1,11% | 2,24% | 1.113.000 |
| 04/10/2004 | 17,74 | 17,88 | 17,59 | 17,59 | -0,59% | 1,63% | 1.058.000 |
| 01/10/2004 | 17,44 | 17,78 | 17,44 | 17,70 | +1,32% | 1,95% | 712.800 |
| 30/09/2004 | 17,28 | 17,55 | 17,20 | 17,47 | +0,95% | 2,00% | 650.000 |
| 29/09/2004 | 16,87 | 17,31 | 16,61 | 17,30 | +2,00% | 4,15% | 833.000 |
| 28/09/2004 | 16,33 | 16,97 | 16,24 | 16,96 | +4,24% | 4,44% | 475.800 |
| 27/09/2004 | 16,54 | 16,58 | 16,14 | 16,27 | -1,45% | 2,63% | 603.200 |
| 24/09/2004 | 16,44 | 16,66 | 16,42 | 16,51 | +0,36% | 1,46% | 181.200 |
| 23/09/2004 | 16,38 | 16,60 | 16,28 | 16,45 | +0,12% | 1,98% | 276.600 |
| 22/09/2004 | 17,04 | 17,06 | 16,39 | 16,43 | -3,69% | 3,93% | 578.000 |
| 21/09/2004 | 16,93 | 17,16 | 16,87 | 17,06 | +0,62% | 1,71% | 417.000 |
| 20/09/2004 | 16,74 | 17,03 | 16,65 | 16,96 | +2,70% | 2,24% | 1.092.400 |
| 17/09/2004 | 16,73 | 16,79 | 16,45 | 16,51 | -0,03% | 2,03% | 542.600 |
| 16/09/2004 | 16,50 | 16,65 | 16,43 | 16,52 | +0,52% | 1,36% | 745.800 |
| 15/09/2004 | 16,11 | 16,48 | 16,05 | 16,43 | +2,18% | 2,64% | 685.800 |
| 14/09/2004 | 16,39 | 16,46 | 15,93 | 16,08 | +0,63% | 3,26% | 754.400 |
| 13/09/2004 | 15,81 | 16,08 | 15,68 | 15,98 | +1,33% | 2,53% | 638.000 |
| 10/09/2004 | 15,22 | 15,85 | 15,17 | 15,77 | +3,24% | 4,47% | 737.800 |
| 09/09/2004 | 15,40 | 15,44 | 15,01 | 15,28 | -0,65% | 2,79% | 632.200 |
| 08/09/2004 | 15,39 | 15,45 | 15,24 | 15,38 | +0,07% | 1,40% | 674.800 |
| 07/09/2004 | 15,38 | 15,56 | 15,13 | 15,37 | -0,13% | 2,80% | 846.600 |
| 03/09/2004 | 15,36 | 15,54 | 15,25 | 15,39 | -0,06% | 1,86% | 267.000 |
| 02/09/2004 | 14,95 | 15,53 | 14,83 | 15,40 | +0,92% | 4,68% | 1.635.800 |
| 01/09/2004 | 14,80 | 15,50 | 14,67 | 15,26 | +2,69% | 5,61% | 1.339.200 |